NEW YORK--(BUSINESS WIRE)--TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced a final call for registration for the 2022 Conversations on Clinical Content (C3) summit. The event is the third in a three-part series and takes place on October 20 in Princeton, NJ. Registration and details can be found at https://thec3summit.com/princeton/.
NEW YORK, Feb. 15, 2022 /PRNewswire/ -- TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced that Innovaderm will scale their implementation of Trial Interactive to further enable and optimize remote clinical operations.
NEW YORK, Nov. 11, 2021 /PRNewswire/ -- TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced the release of the Trial Interactive (TI) Clinical Trial Management System (CTMS). This release marks the industry's only mobile-first CTMS, placing important actions and information at the fingertips of study managers and CRAs and supporting a full author-to-archive process.
NEW YORK--(BUSINESS WIRE)--TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced the inaugural summit in its new thought leadership series, C3: Conversations on Clinical Content. Held from October 13-15, the virtual conference will feature a series of industry expert-led webinars focused on remote trial management and TMF insights.
TransPerfect Life Sciences, a leading provider of services and technologies to support global product development for the life sciences industry, has released version 1.2 of myTI, the mobile application that enables real-time eTMF management and oversight for study teams on the go. This new release of the mobile version of the Trial Interactive e-clinical platform simplifies CRA site visits, providing even more ways to speed timelines and reduce risk.